Determinants of activity of the HIV-1 maturation inhibitor PA-457

被引:55
作者
Li, Feng
Zoumplis, Dorian
Matallana, Claudia
Kilgore, Nicole R.
Reddick, Mary
Yunus, Abdul S.
Adamson, Catherine S.
Salzwedel, Karl
Martin, David E.
Allaway, Graham P.
Freed, Eric O.
Wild, Carl T.
机构
[1] Panacos Pharmaceut, Gaithersburg, MD 20877 USA
[2] NCI, HIV Drug Resistance Program, Frederick, MD 21702 USA
关键词
PA-457; HIV; maturation inhibitor; CA-SP1; cleavage; viral determinants;
D O I
10.1016/j.virol.2006.07.023
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
3-0-(3',3'-dimethylsuccinyl) betulinic acid, also termed PA-457 or DSB, is a novel HIV-1 inhibitor that blocks virus maturation by disrupting cleavage of the capsid precursor, CA-SP1. To better define the molecular target for PA-457, we prepared a panel of mutant viruses with point deletions spanning the CA-SP1 cleavage domain and characterized each of these viruses for PA-457 sensitivity. Our results indicate that amino acid residues in the N-terminal half of SP1 serve as determinants of PA-457 activity, while residues in the C-terminal half of SP1 were not involved in compound activity. These findings support and extend previous observations that PA-457 is a specific inhibitor of CA-SP1 cleavage and identify the CA-SP1 domain as the primary viral determinant for this novel inhibitor of HIV-1 replication. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:217 / 224
页数:8
相关论文
共 41 条
[1]   A putative α-helical structure which overlaps the capsid-p2 boundary in the human immunodeficiency virus type 1 Gag precursor is crucial for viral particle assembly [J].
Accola, MA ;
Höglund, S ;
Göttlinger, HG .
JOURNAL OF VIROLOGY, 1998, 72 (03) :2072-2078
[2]   Overexpression of the N-terminal domain of TSG101 inhibits HIV-1 budding by blocking late domain function [J].
Demirov, DG ;
Ono, A ;
Orenstein, JM ;
Freed, EO .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (02) :955-960
[3]   The late domain of human immunodeficiency virus type 1 p6 promotes virus release in a cell type-dependent manner [J].
Demirov, DG ;
Orenstein, JM ;
Freed, EO .
JOURNAL OF VIROLOGY, 2002, 76 (01) :105-117
[4]   FUNCTIONAL DOMAINS OF THE CAPSID PROTEIN OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 [J].
DORFMAN, T ;
BUKOVSKY, A ;
OHAGEN, A ;
HOGLUND, S ;
GOTTLINGER, HG .
JOURNAL OF VIROLOGY, 1994, 68 (12) :8180-8187
[5]   CLEAVAGE OF HIV-1 GAG POLYPROTEIN SYNTHESIZED INVITRO - SEQUENTIAL CLEAVAGE BY THE VIRAL PROTEASE [J].
ERICKSONVIITANEN, S ;
MANFREDI, J ;
VIITANEN, P ;
TRIBE, DE ;
TRITCH, R ;
HUTCHISON, CA ;
LOEB, DD ;
SWANSTROM, R .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1989, 5 (06) :577-591
[6]   HIV-1 Gag proteins: Diverse functions in the virus life cycle [J].
Freed, EO .
VIROLOGY, 1998, 251 (01) :1-15
[7]   Tsg101 and the vacuolar protein sorting pathway are essential for HIV-1 budding [J].
Garrus, JE ;
von Schwedler, UK ;
Pornillos, OW ;
Morham, SG ;
Zavitz, KH ;
Wang, HE ;
Wettstein, DA ;
Stray, KM ;
Côté, M ;
Rich, RL ;
Myszka, DG ;
Sundquist, WI .
CELL, 2001, 107 (01) :55-65
[8]   EFFECT OF MUTATIONS AFFECTING THE P6 GAG PROTEIN ON HUMAN-IMMUNODEFICIENCY-VIRUS PARTICLE RELEASE [J].
GOTTLINGER, HG ;
DORFMAN, T ;
SODROSKI, JG ;
HASELTINE, WA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (08) :3195-3199
[9]   SITE-DIRECTED MUTAGENESIS BY OVERLAP EXTENSION USING THE POLYMERASE CHAIN-REACTION [J].
HO, SN ;
HUNT, HD ;
HORTON, RM ;
PULLEN, JK ;
PEASE, LR .
GENE, 1989, 77 (01) :51-59
[10]   P6(GAG) IS REQUIRED FOR PARTICLE-PRODUCTION FROM FULL-LENGTH HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 MOLECULAR CLONES EXPRESSING PROTEASE [J].
HUANG, MJ ;
ORENSTEIN, JM ;
MARTIN, MA ;
FREED, EO .
JOURNAL OF VIROLOGY, 1995, 69 (11) :6810-6818